U.S. gives go-ahead on publication of H5N1 research; Dutch regulators continue to debate

NewsGuard 100/100 Score

The U.S. government on Friday formally accepted a recommendation from the National Science Advisory Board for Biosecurity (NSABB) "to publish two controversial studies of the H5N1 avian influenza virus, moving the pair of papers another step closer to publication," ScienceInsider reports (Malakoff, 4/20). "Groups led by the two scientists -- Yoshihiro Kawaoka of the University of Wisconsin and Ron Fouchier of Erasmus Medical Center in Rotterdam -- engineered the H5N1 virus to be more transmissible between ferrets, mammals whose response to the flu is most like humans," Bloomberg Businessweek notes. "The research is critical to understanding and detecting bird flu strains, Health and Human Services Secretary Kathleen Sebelius and Francis Collins, director of the National Institutes of Health, said [on Friday] in a statement," Bloomberg writes, noting that the NSABB "recommended in March that Sebelius and Collins approve publication" (Wayne, 4/20).

However, "Kathy Wren, a spokeswoman for Science, which is withholding the Fouchier study, said the journal is still waiting for a decision by Dutch regulators [this] week before deciding when it will publish the research, Bloomberg News reported," according to HealthDay News (4/23). According to ScienceInsider, "the Dutch Ministry of Foreign Affairs in The Hague is hosting a meeting [on Monday] to discuss the security implications of the H5N1 research" and to "decid[e] whether it will invoke export-control laws in a bid to prevent Fouchier from submitting a revised version of his paper to Science" (4/20). "It's unclear when government officials will make any formal decision," NPR's "Shots" blog writes. "But if the Dutch government refuses to lift the export control, Fouchier could submit his paper to the journal without applying for permission and face the consequences," the blog notes (Greenfieldboyce, 4/20).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis